scholarly journals A Randomized, Double-Blind, Placebo-Controlled Study of Preemptive Oral Oxycodone with Morphine Patient-Controlled Anesthesia for Postoperative Pain Management in Patients Undergoing Uterine Artery Embolization for Symptomatic Uterine Fibroids

2014 ◽  
Vol 37 (5) ◽  
pp. 1191-1197 ◽  
Author(s):  
Alex H. Konstantatos ◽  
Helen Kavnoudias ◽  
James R. Stegeman ◽  
Dana Boyd ◽  
Maryann Street ◽  
...  
Keyword(s):  
Pain Management ◽  
Postoperative Pain ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Fibroids ◽  
Postoperative Pain Management ◽  
Controlled Study ◽  
Artery Embolization ◽  
Double Blind ◽  
Double Blind Placebo

Valdecoxib for Postoperative Pain Management After Cesarean Delivery: A Randomized, Double-Blind, Placebo-Controlled Study

2006 ◽  
Vol 103 (3) ◽  
pp. 664-670 ◽  
Author(s):  
Brendan Carvalho ◽  
Larry Chu ◽  
Andrea Fuller ◽  
Sheila E. Cohen ◽  
Edward T. Riley
Keyword(s):  
Pain Management ◽  
Postoperative Pain ◽  
Cesarean Delivery ◽  
Postoperative Pain Management ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids – A Retrospective Evaluation

2020 ◽  
Author(s):  
Amer Malouhi ◽  
Rene Aschenbach ◽  
Anna Erbe ◽  
Zbigniew Owsianowski ◽  
Stefan Rußwurm ◽  
...  
Keyword(s):  
Pain Management ◽  
Pain Score ◽  
Epidural Anesthesia ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Fibroids ◽  
Artery Embolization ◽  
Hypogastric Plexus ◽  
Superior Hypogastric Plexus ◽  
Plexus Block

Purpose To assess the effectiveness of pain management with superior hypogastric plexus block (SHPB) compared to epidural anesthesia (EDA) in women requiring uterine artery embolization (UAE). Materials and Methods In this retrospective, single-center, non-randomized trial we included 79 women with symptomatic uterine fibroids who were scheduled for percutaneous, transcatheter UAE. According to their informed decision, the women were assigned to two different approaches of pain management including either SHPB or EDA. The effectiveness outcome measure was patient reported pain using a numeric rating scale ranging from 1 to 10. The pain score was assessed at UAE, 2 hours thereafter, and at subsequent intervals of 6 hours up to 36 hours after intervention. Results Treatment groups did not differ significantly regarding age, pain score for regular menstrual cramps, uterine fibroid size, location, and symptoms of uterine fibroids. During UAE and up to 6 hours thereafter, women who received SHPB experienced stronger pain than those who received EDA (mean pain score during UAE: 3.3 vs. 1.5, p < 0.001; at 2 hours: 4.4 vs. 2.8, p = 0.012; at 6 hours: 4.4 vs. 2.6, p = 0.021). The maximum pain level was 5.8 ± 2.9 with SHPB and 4.5 ± 2.9 with EDA (p = 0.086). Women with a history of severe menorrhagia tended to experience worse pain than those without (regression coefficient 2.5 [95 % confidence interval –0.3 to 5.3], p = 0.076). Conclusion Among women who underwent UAE, pain management including SHPB resulted in stronger pain during and after the procedure than pain treatment including EDA. Key Points: Citation Format

scholarly journals Pain Management During Uterine Artery Embolization for Symptomatic Uterine Fibroids

2007 ◽  
Vol 30 (4) ◽  
pp. 809-811 ◽  
Author(s):  
L. E. Lampmann ◽  
P. N. Lohle ◽  
A. Smeets ◽  
P. F. Boekkooi ◽  
H. Vervest ◽  
...  
Keyword(s):  
Pain Management ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Fibroids ◽  
Artery Embolization
Sign in / Sign up

Export Citation Format

Share Document